Biotickr logobiotickr

Company Description

Virpax Pharmaceuticals specializes in developing novel and proprietary drug-delivery systems across various pain and CNS disorder indications to enhance compliance and to optimize the efficacy of each product candidate.

Our transforming drug-delivery platforms and their targeted drug-releasing capabilities have been developed to optimize the efficacy of our non-addictive pain management pipeline and our CNS disorder pipeline. Virpax® Pharmaceuticals (Nasdaq: VRPX) is a publicly held specialty pharmaceutical company located in Berwyn, PA and is focused on advancing the development and worldwide commercialization of its non-addictive pain and neurological disorder pipeline.

Technology

Virpax Pharmaceuticals specializes in developing novel and proprietary drug-delivery systems across various pain and CNS disorder indications to enhance compliance and to optimize the efficacy of each product candidate.

Our transforming drug-delivery platforms and their targeted drug-releasing capabilities have been developed to optimize the efficacy of our non-addictive pain management pipeline and our CNS disorder pipeline.

Drug Pipeline

Source: Virpax Pharmaceuticals Inc - 20221129
Asset
Indication
Phase
AnQlar
COVID-19
Preclinical
 
 
 
 
 
Influenza
Preclinical
 
 
 
 
 
Envelta
Pain
Preclinical
 
 
 
 
 
Epoladerm
Pain
Phase 1
 
 
 
 
 
Probudur
Pain Management
Preclinical
 
 
 
 
 
VRP324
Epilepsy
Preclinical
 
 
 
 
 

Conversation

0 following
Messages Image
Log in or sign up to join the conversation.

0 Comments on VRPX stock

Newest